跳至主要内容
临床试验/NCT07164209
NCT07164209已完成不适用

Resection of the Mesentery With Functional End-to-end Anastomosis vs Kono Anastomosis in Preventing Relapse After Ileocolic Resection for Primary Crohn Disease: a Prospective, Randomized, Controlled Trial Remeasure CD TRial

Azienda Ospedaliera Ordine Mauriziano di Torino2 个研究点 分布在 1 个国家目标入组 73 人开始时间: 2022年1月2日最近更新:

试验速览

阶段
不适用
状态
已完成
入组人数
73
试验地点
2
主要终点
endoscopic recurrence (Rutgeerts score i2 or greater) at 6,12, 18 months.Endoscopic recurrence was defined if Rutgeerts > i2 (>5 aphthous lesions or larger lesions confined to anastomosis), i3 (diffuse ileitis), or i4 (diffuse inflammation with large ulc

研究概览

简要总结

Aim of the present study is to compare a stapled, functional end-to-end, ileo-colic anastomosis with removal of the mesentery vs the manual, functional end-to-end, ileo-colic Kono-S anastomosis with mesentery preservation, in terms of peri-operative safety, and efficacy in preventing endoscopic recurrence after ileocolic resection for Crohn Disease. Patients presenting with ileocolic primary Crohn disease either not suitable for medical treatment or with contraindications for therapy i.e: occlusion, abscess, contraindications to the use of biologics

详细描述

Patients who meet inclusion criteria will be randomized between two surgical procedures:

The excision of the mesentery (group A) and ileocolic anastomosis and the Kono-S anastomosis (group B) after ileocolic or ileo-cecal resection. The operation could be performed with open or laparoscopic approach.

Excision of the mesentery:

the mesentery is fully dissected and excised to the limit of macroscopic "fat wrapping", where mesenteric fat is inflamed and extends beyond its normal anatomical distribution over the surface of the contiguous intestine. The anastomosis between colon and ileum is than performed mechanically end to end.

Kono-S anastomosis:

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 70 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • • Patients > 18 years
  • Histological diagnosis of Crohn's Disease
  • Patient's ability to read and understand the documentation concerning the study and the Informed consent
  • Ileocolic disease requiring resection

排除标准

  • Older than 70
  • Recurrent disease, previous surgery for CD
  • Gastroenterologists or patients not willing to maintain a drug washout for six months
  • Emergency surgery

结局指标

主要结局

endoscopic recurrence (Rutgeerts score i2 or greater) at 6,12, 18 months.Endoscopic recurrence was defined if Rutgeerts > i2 (>5 aphthous lesions or larger lesions confined to anastomosis), i3 (diffuse ileitis), or i4 (diffuse inflammation with large ulc

时间窗: From the treatment a close follow up is performed at 6, 12 and 18 months.The majority of endoscopic examinations were centrally performed. In few cases check was performed in separated centers and a "recording video clip" of the endoscopy was assessed fo

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Lucia Borsotti

Michela Mineccia, MD

Azienda Ospedaliera Ordine Mauriziano di Torino

研究点 (2)

Loading locations...

相似试验

The Remeasure Trial | 临床试验